Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study to evaluate the safety of ADX-038 in patients with complement-mediated kidney disease
ItalyA study of MK-1084 and a drug combination for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations.
ItalyA study to evaluate the safety and effectiveness of VTX2735 sodium in patients with recurrent pericarditis
ItalyA study of donidalorsen for children with hereditary angioedema
ItalyComparing the effectiveness of nepafenac and dexamethasone sodium phosphate for treating eye inflammation after cataract surgery
ItalyObinutuzumab treatment for adults with frequently relapsing idiopathic nephrotic syndrome who are dependent on rituximab
ItalyA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
ItalyA study to evaluate the efficacy and safety of etrasimod arginine in children with moderately to severely active ulcerative colitis
ItalyA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
ItalyA study to compare the effectiveness of EL219 against liposomal amphotericin B and voriconazole for patients with suspected invasive mould infections.
ItalyA study to evaluate the safety and effectiveness of empasiprubart and efgartigimod alfa in patients with generalized myasthenia gravis.
ItalyA study of IM-101 in adults with generalized myasthenia gravis or ocular myasthenia gravis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
